Skip to main content
Equibles
ABPO logo

ABPO · Abpro Holdings, Inc.

Track ABPO — free

Use ABPO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ABPO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.40 +0.04 (+12.59%) At close · Oct 21
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Accordingly, based on the considerations discussed above, management has concluded there is substantial doubt as to the Company's ability to continue as a going concern within one year after the date these unaudited condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$2.36M
Shares
5.90M
Volume · Oct 21 20.05K Avg daily vol (3M) 11.27K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.40 Open$0.39 Day$0.39–0.43 52W close$0.10–7.04 Avg vol 30d15K Short int16K · 0.3% float · 1.0d Short vol91% DataMar 2022–Oct 2026 Filing10-Q · Aug 14

Up next

Latest filing: 10-Q
filed Aug 14, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
$2.01M
Trailing 12 months
Revenue growth YoY
+50.0%
Year over year
Operating margin
-5,421.3%
Trailing 12 months
P / E (TTM)
0.2
Trailing earnings · reciprocal yield 539.3%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$4.24M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+207.5%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.3%
Latest settlement · 1.0 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Strong Sentiment Bearish Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 16.7 · calm Equity put/call 0.52
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −31%
below
Price vs 50-day avg +35%
above
RSI (14) 59
neutral
MACD trend Negative
52-week position 4%
near low
Momentum
relative strength
Strong
1-month return +11%
trailing
6-month return +111%
trailing
YTD return −91%
this year
Relative strength +103%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Distributing
-89% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.27% of float · ▲ +31.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
4 holders — near 3-yr low, contrarian setup
Squeeze score 50
elevated · 0–100
Fundamentals
Strong
Revenue growth +50%
Y/Y
EPS growth +94%
Y/Y
Free cash flow $-6.1M
Quant / Vol
risk profile
Very High
Volatility 198%
annualized · 1-yr
Max drawdown −99%
past year
ATR 9.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−31% Bearish
Price vs 50-day avg
+35% Bullish
RSI (14)
59 Neutral
MACD trend
Negative Bearish
52-week position
4% Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Distributing
-89% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.27% of float · ▲ +31.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
4 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $0 · 4% Range high $7
vs 200-day avg -31% vs 50-day avg +35%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ABPO
Abpro Holdings, Inc.
this stock
$2.36M -90.5% +50.0% — 0.3%
VRTX
Vertex Pharmaceuticals Inc
 $131.39B +15.7% +46.2% 30.2 1.8%
MRNA
Moderna, Inc.
 $98.14B +733.5% +4.3% — 7.7%
REGN
Regeneron Pharmaceuticals, Inc.
 $83.13B +4.4% +20.8% 20.0 2.1%
CSLLY
Csl Ltd
 $66.22B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
4
% held
7.3%
Net QoQ
-8.3M sh
Top holder
Diametric Capital, LP
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
16.1K
Days to cover
1.0d
Change
+3.9K sh
View
Short Volume
Short vol %
91%
As of
Oct 20, 2026
Short Total
View
Fails to Deliver
FTD shares
747
Value
$149
As of
Jun 17, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$183.0K
Net income (FY)
$2.8M
EPS diluted
$-1.30
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 1, 2026
This year
12
View

Performance

5D 20D 120D MTD YTD
ABPO +12.7% +11.3% +110.8% +13.5% -90.5%
SPY +0.5% +0.7% +7.6% +1.4% +13.4%
vs SPY +12.2% +10.6% +103.2% +12.1% -103.9%
Key facts CIK 1893219 CUSIP 000847202 Visit website